Changes in cancer-related mortality during the COVID-19 pandemic in the United States

被引:13
|
作者
Fedeli, Ugo [1 ,3 ]
Barbiellini Amidei, Claudio [1 ]
Han, Xuesong [2 ]
Jemal, Ahmedin [2 ]
机构
[1] Azienda Zero, Epidemiol Dept, I-35132 Padua, Italy
[2] Amer Canc Soc, Surveillance & Hlth Equ Sci Dept, Atlanta, GA USA
[3] Epidemiol Dept, Via Avanzo 35, I-35132 Padua, Italy
来源
关键词
D O I
10.1093/jnci/djad191
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Few studies have examined cancer-related mortality overall, never mind select cancer types, during the COVID-19 pandemic. Data on cancer-related mortality (any mention in death certificates, multiple causes of death approach) was extracted from the US Centers for Disease Control and Prevention WONDER database. Changes in trends for age-standardized mortality rates through 1999-2021 were assessed by Joinpoint analysis. In total, 1 379 643 cancer-related deaths were registered in 2020-2021, with cancer selected as the underlying cause in 88%. After 2 decades of decline, age-standardized cancer-related mortality increased from 2019 to 2021 for all cancers (annual percentage change = 1.6%, 95% confidence interval = 0.6% to 2.6%), especially for prostate cancer (annual percentage change = 5.1%, 95% confidence interval = 2.2% to 8.2%) and hematologic cancers (annual percentage change = 4.8%, 95% confidence interval = 3.1% to 6.6%). Sharp peaks in cancer-related deaths for many cancer sites were observed during pandemic waves in both 2020 and 2021, mostly attributed to COVID-19 as the underlying cause. Multiple causes of death analyses are warranted to fully assess the impact of the pandemic on cancer-related mortality.
引用
收藏
页码:167 / 169
页数:3
相关论文
共 50 条
  • [21] Beyond COVID-19 deaths during the COVID-19 pandemic in the United States
    Jacobson, Sheldon H.
    Jokela, Janet A.
    HEALTH CARE MANAGEMENT SCIENCE, 2021, 24 (04) : 661 - 665
  • [22] Beyond COVID-19 deaths during the COVID-19 pandemic in the United States
    Sheldon H. Jacobson
    Janet A. Jokela
    Health Care Management Science, 2021, 24 : 661 - 665
  • [23] Increased mortality of patients with alcohol-related liver diseases during the COVID-19 pandemic in the United States
    Yeo, Yee Hui
    Zou, Biyao
    Cheung, Ramsey
    Nguyen, Mindie H.
    JOURNAL OF INTERNAL MEDICINE, 2022, 292 (05) : 837 - 839
  • [24] HIV-related mortality in the United States during the COVID-19 pandemic: A population-based study
    He, Xinyuan
    Lv, Fan
    Fox, Marissa
    Yeo, Yee Hui
    Zou, Biyao
    Liu, Jinli
    Zhao, Yunyu
    Zu, Jian
    Li, Yan
    Tang, Weiming
    Zhang, Lei
    Ji, Fanpu
    JOURNAL OF INTERNAL MEDICINE, 2023, 294 (02) : 178 - 190
  • [25] Changes in Breast Cancer Screening Prevalence in the United States during the COVID-19 Pandemic, 2018 to 2022
    Ashad-Bishop, Kilan C.
    Star, Jessica
    Giaquinto, Angela N.
    Smith, Robert A.
    Jemal, Ahmedin
    Bandi, Priti
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2025, 34 (01) : 133 - 138
  • [26] Excess mortality in the United States during the first three months of the COVID-19 pandemic
    Rivera, R.
    Rosenbaum, J. E.
    Quispe, W.
    EPIDEMIOLOGY AND INFECTION, 2020, 148
  • [27] Immigrant mortality advantage in the United States during the first year of the COVID-19 pandemic
    Paglino, Eugenio
    Elo, Irma T.
    DEMOGRAPHIC RESEARCH, 2024, 50
  • [28] Medicaid expansion and drug overdose mortality during the COVID-19 pandemic in the United States
    Auty, Samantha G.
    Griffith, Kevin N.
    DRUG AND ALCOHOL DEPENDENCE, 2022, 232
  • [29] Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters
    London, Jack W.
    Fazio-Eynullayeva, Elnara
    Palchuk, Matvey B.
    Sankey, Peter
    McNair, Christopher
    JCO CLINICAL CANCER INFORMATICS, 2020, 4 : 657 - 665
  • [30] Impact of COVID-19 Pandemic on Cancer-Related Hospitalizations in Brazil
    da Costa, Allini Mafra
    Ribeiro, Aline L.
    Ribeiro, Adeylson G.
    Gini, Andrea
    Cabasag, Citadel
    Reis, Rui M.
    Fregnani, Jose Humberto T. G.
    Soerjomataram, Isabelle
    CANCER CONTROL, 2021, 28